cancer drugs
Infographic: Cancer Drug Pairings
Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018
Researchers use several different strategies to deliver a one-two punch.
Sanofi and Celgene Spend $20 Billion in Major Biotech Acquisitions
Sanofi and Celgene Spend $20 Billion in Major Biotech Acquisitions
Katarina Zimmer | Jan 23, 2018
Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.
AbbVie Wins Bidding War for Cancer Drugmaker
AbbVie Wins Bidding War for Cancer Drugmaker
Bob Grant | Mar 5, 2015
The pharmaceutical firm beat out a host of potential suitors, Johnson & Johnson among them, to strike a $21 billion deal with Pharmacyclics.
Lavish Spending at MD Anderson
Lavish Spending at MD Anderson
Kate Yandell | May 28, 2013
The public cancer center is criticized for allegedly devoting at least $1.5 million to remodeling an executive suite.
Spinning Clinical Trials
Spinning Clinical Trials
Dan Cossins | Jan 16, 2013
Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.
$18M Grant to Be Re-reviewed
Jef Akst | Jun 1, 2012
A Texas cancer institute is taking a second look at the largest grant it ever awarded after concerns were raised that the proposal never received proper scientific review.
Collecting Cancer Data
Hannah Waters | Mar 29, 2012
Two new cancer cell line databases bursting with genomic and drug profiling data may help researchers identify drug targets.